No abstract available
MeSH terms
-
Alemtuzumab / adverse effects
-
Humans
-
Multiple Sclerosis* / complications
-
Multiple Sclerosis* / drug therapy
-
Multiple Sclerosis, Relapsing-Remitting* / drug therapy
-
Myelodysplastic Syndromes* / complications
-
Myelodysplastic Syndromes* / drug therapy